RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 1 filers reported holding RA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $15,701,000 | +74.9% | 327,045 | +70.9% | 0.19% | +250.9% |
| Q4 2019 | $8,979,000 | +5730.5% | 191,337 | +559.9% | 0.05% | +5200.0% |
| Q1 2018 | $154,000 | -46.2% | 28,997 | -14.0% | 0.00% | 0.0% |
| Q4 2017 | $286,000 | -5.3% | 33,700 | +137.8% | 0.00% | 0.0% |
| Q1 2017 | $302,000 | +46.6% | 14,170 | +4.3% | 0.00% | 0.0% |
| Q4 2016 | $206,000 | – | 13,580 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|